---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-013314"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:24:19.269498+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Director Lee Rauch resigns from Ensysce board over severance package dispute

## Summary
- Lee Rauch resigned effective March 24, 2026, citing disagreement with board-approved severance packages.
- Packages provide up to $205,475 in potential severance for CFO and three managers during strategic review.
- CFO retention package increased from 6 to 9 months; packages contingent on non-retention in any strategic deal.
- Board approved packages on March 27, 2026; Rauch had previously expressed other disagreements.
- Company continues evaluating strategic alternatives for its business.

## SEC filing metadata
- accession: 0001493152-26-013314
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315226013314/0001493152-26-013314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315226013314/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-013314
- JSON: https://secwatch.observer/filing/0001493152-26-013314.json
- Plain text: https://secwatch.observer/filing/0001493152-26-013314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.